OOIR: Observatory of International Research

Papers

(The median citation count of Annual Review of Cancer Biology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Immune Cell Metabolism and Immuno-Oncology	103
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo	33
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer	33
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond	32
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance	32
Mitochondria, OXPHOS, and Cancer Progression: A Modular View	31
Lessons from 3D Reconstruction of Cancer	26
Natural and Engineered Cytokines as Cancer Therapeutics	21
Allogeneic CAR T Cell Therapy for Cancer	21
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?	20
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity	17
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology	16
Road Map to Defeat Pancreatic Cancer	15
Cancer Cell Polarity and Extrusion	14
An Erratic Path Toward Discovery	14
Cancer Dependency Map: Past and Present	14
Engineering Cancer with Next-Generation Genome Editing Tools	14
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies	14
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance	13
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy	12
Targeting RAS for Cancer Treatment: What a Long, Strange Trip It's Been	12
Reinventing Radiobiology in the Light of FLASH Radiotherapy	12
The Angiocrine Niche in Cancer Therapy Responses: The Role of Vascular Endothelial Cells in Immunomodulation	11
Strategies for Heating Up Cold Tumors to Boost Immunotherapies	10
Engineering the Immune Microenvironment into Organoid Models	10

Targeting Minimal Residual Disease	8
Mechanism of Action of PARP Inhibitors	8
Glycosylation in Cancer: From Functional Roles to Therapeutic Implications	8
Extrachromosomal DNA: Biogenesis and Functions in Cancer	8
Metabolic Rewiring During Metastasis: The Interplay Between the Environment and the Host	6
Antibody–Drug Conjugates: The Past, Present and Future	6
Transcriptional and Epigenetic Regulation of T Cell States in Cancer	6
Next-Generation Therapies for Multiple Myeloma	5
	5
Cancer Predisposition in Li-Fraumeni Syndrome	4
Cancer Dormancy as a Collective Phenomenon Across Scales in Length and Time: Biological Observations and Advanced 3D Bioengineered Models	4
Metabolic Reprogramming in Cancer Cachexia	4
Not All Carcinogens Are Directly Mutagenic: A Holistic View of the Environmental Exposure–Cancer Connection	4
Lineage-Specific Transcription Factors in Carcinogenesis	3
DNA-Encoded Libraries in Cancer Research: Recent Landmarks and Future Promises	3
Designing the Perfect Strike Against Cancer: Clocking In with the Circadian Rhythm	3
Emerging Mechanisms of Lactate Regulation of Biological Processes	3
Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of Cancer	3